Sanofi (SNY) Signs Deal for AI-Powered Drug Development

Published on 19 May 2024 on Zacks · via Yahoo Finance

Sanofi (SNY) Signs Deal for AI-Powered Drug Development

Sanofi SNY announced that it has entered into a first-in-class artificial intelligence (AI) collaboration with Formation Bio and OpenAI to build AI-powered software to expedite the development of drugs.

Formation Bio is a tech-driven, AI-native pharma company focused on bringing new treatments to patients with more efficient drug development, while OpenAI is an AI research and deployment company.

Read the rest of the article

NASDAQ.GBIO price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Is Nuvation Bio Inc. (NUVB) Hedge Funds’ Favorite Penny Stock?

We recently published a list of 10 Most Promising Penny Stocks According to Hedge Funds. In this ...

Insider Monkey · via Yahoo Finance 14 Oct 2024

Insider Buyers At Generation Bio Sitting On US$1.1m Profit

Insiders who bought Generation Bio Co. (NASDAQ:GBIO) in the last 12 months may probably not pay a...

Simply Wall St. via Yahoo Finance 23 May 2024

Sanofi (SNY) Signs Deal for AI-Powered Drug Development

Sanofi SNY announced that it has entered into a first-in-class artificial intelligence (AI) colla...

Zacks · via Yahoo Finance 19 May 2024

Generation Bio Co. (GBIO) Reports Q4 Loss, Lags Revenue Estimates

Generation Bio Co. (GBIO) came out with a quarterly loss of $0.53 per share versus the Zacks Cons...

Zacks via Yahoo Finance 6 Mar 2024

Malibu environmental advocate and entrepreneur makes presentations at COP28 in Dubai • The Malibu...

As waves crash mercilessly against Malibu’s coastline due to atmospheric rivers and El Nino’s...

The Malibu Times 6 Jan 2024

GenScript Biotech Global Forum 2024 to Commence, Infusing New Vitality into the GCT Industry

On January 10, 2024, the GenScript Biotech Global Forum is set to inaugurate with grandeur during...

FOX40 Sacramento 4 Jan 2024

As Cohen Milstein Grows, Law Firm Names New Managing Partner | National Law Journal

Toll remains a partner at the firm and co-chair of the securities litigation and investor protect...

Law.com 3 Jan 2024

Why Fisker Shares Are Trading Higher By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day...

Why Fisker Shares Are Trading Higher By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Da...

Investing.com 29 Dec 2023

FDA Keynote Speaker in the Spotlight, CAR-T Industry Leaders Gather for Discussion-Join the 2024...

The innovative development of biopharmaceuticals has ushered in a new era for disease treatment,...

FOX 59 Indianapolis 25 Dec 2023

US Stocks Mostly Lower; FedEx Earnings Miss Estimates - bluebird bio (NASDAQ:BLUE), Asset Entities...

U.S. stocks traded mostly lower this morning, with the Dow Jones index falling around 75 points o...

Benzinga 20 Dec 2023

News

Sanofi (SNY) Signs Deal for AI-Powered Drug Development

NASDAQ.GBIO price evolution

Want to become a better investor?